UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 156

Sortiert nach

Severe thrombotic events associated with pre-procedural interruption of anticoagulation in systemic lupus erythematosus with secondary antiphospholipid syndrome: Cases and literature review

Lupus, 2022-02, Vol.31 (2), p.261-267

2022

Link zum Volltext

Verfügbarkeit prüfen

Autoantibody-mediated impairment of DNASE1L3 activity in sporadic systemic lupus erythematosus

The Journal of experimental medicine, 2021-05, Vol.218 (5)

2021

Link zum Volltext

Verfügbarkeit prüfen

The Incidence and Prevalence of Systemic Lupus Erythematosus in New York County (Manhattan), New York: The Manhattan Lupus Surveillance Program

Arthritis & rheumatology (Hoboken, N.J.), 2017-10, Vol.69 (10), p.2006-2017

2017

Link zum Volltext

Verfügbarkeit prüfen

C3 glomerulonephritis and systemic lupus erythematosus: A report of a patient treated with eculizumab and review of the literature

Lupus, 2021-09, Vol.30 (10), p.1671-1678

2021

Link zum Volltext

Verfügbarkeit prüfen

Population-based prevalence and incidence estimates of mixed connective tissue disease from the Manhattan Lupus Surveillance Program

Rheumatology (Oxford, England), 2023-08, Vol.62 (8), p.2845-2849

2023

Link zum Volltext

Verfügbarkeit prüfen

Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective study

Arthritis research & therapy, 2020-08, Vol.22 (1), p.1-191, Article 191

2020

Link zum Volltext

Verfügbarkeit prüfen

Microvascular C5b-9 deposition in non-lesional skin in patients with SLE and its correlation with active lupus nephritis: a prospective observational study

Lupus science & medicine, 2023-10, Vol.10 (2), p.e000996

2023

Link zum Volltext

Verfügbarkeit prüfen

Mild Clinical Course of COVID-19 in 3 Patients Receiving Therapeutic Monoclonal Antibodies Targeting C5 Complement for Hematologic Disorders

The American journal of case reports, 2020-09, Vol.21, p.e927418-e927418

2020

Link zum Volltext

Verfügbarkeit prüfen

Modeling of clinical phenotypes in systemic lupus erythematosus based on the platelet transcriptome and FCGR2a genotype

Journal of translational medicine, 2023-04, Vol.21 (1), p.247-247, Article 247

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinical implications of discordance between anti-dsDNA antibodies by multiplex flow immunoassay and Crithidia luciliae assay in a multiethnic racial cohort of patients with SLE

Lupus science & medicine, 2023-11, Vol.10 (2), p.e001012

2023

Link zum Volltext

Verfügbarkeit prüfen

Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)

Lupus, 2022-12, Vol.31 (14), p.1770-1776

2022

Link zum Volltext

Verfügbarkeit prüfen

Hydroxychloroquine is associated with lower platelet activity and improved vascular health in systemic lupus erythematosus

Lupus science & medicine, 2021-03, Vol.8 (1), p.e000475

2021

Link zum Volltext

Verfügbarkeit prüfen

Membrane attack complex (MAC) deposition in renal tubules is associated with interstitial fibrosis and tubular atrophy: a pilot study

Lupus science & medicine, 2022-01, Vol.9 (1), p.e000576

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical and Serologic Phenotyping and Damage Indices in Patients With Systemic Lupus Erythematosus With and Without Fibromyalgia

ACR open rheumatology, 2024-04, Vol.6 (4), p.172-178

2024

Link zum Volltext

Verfügbarkeit prüfen

306 Persistence of urinary biomarkers of intrarenal inflammation precedes loss of kidney function in lupus nephritis

Lupus science & medicine, 2024-05, Vol.11 (Suppl 2), p.A22-A23

2024

Link zum Volltext

Verfügbarkeit prüfen

O38 Persistence of urinary biomarkers of intrarenal inflammation precedes loss of kidney function in lupus nephritis

Lupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A36-A36

2024

Link zum Volltext

Verfügbarkeit prüfen

Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy

The New England journal of medicine, 2024-04, Vol.390 (13), p.1245-1246

2024

Link zum Volltext

Verfügbarkeit prüfen

Erythrocyte complement receptor 1 (ECR1) and erythrocyte-bound C4d (EC4d) in the prediction of poor pregnancy outcomes in systemic lupus erythematosus (SLE)

Lupus science & medicine, 2022-09, Vol.9 (1), p.e000754

2022

Link zum Volltext

Verfügbarkeit prüfen

2023 ACR/EULAR antiphospholipid syndrome classification criteria

Annals of the rheumatic diseases, 2023-10, Vol.82 (10), p.1258

2023

Link zum Volltext

Verfügbarkeit prüfen

A Woman With Painful Digital Ulcers

JAMA : the journal of the American Medical Association, 2022-04, Vol.327 (16), p.1608

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 156

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(134)
Mit Volltextzugriff
(137)

Publikationsform

Sprache

Englisch
(156)
Japanisch
(20)

Erscheinungsjahr

n.n

Thema

Science & Technology
(109)
Life Sciences & Biomedicine
(107)
Humans
(93)
Rheumatology
(58)
Female
(50)
Adult
(37)
Lupus
(32)
Male
(32)
Systemic Lupus Erythematosus
(30)
Middle Aged
(27)
Biological And Medical Sciences
(25)
Lupus Nephritis
(21)
Autoimmune Diseases
(20)
Biopsy
(20)
Medical Sciences
(19)
Antiphospholipid Syndrome
(18)
Patients
(17)
Lupus Erythematosus, Systemic - Complications
(16)
Antiphospholipid Antibodies
(15)
Clinical Trials
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Severe thrombotic events associated with pre-procedural interruption of anticoagulation in systemic lupus erythematosus with secondary antiphospholipid syndrome: Cases and literature review

Autoantibody-mediated impairment of DNASE1L3 activity in sporadic systemic lupus erythematosus

The Incidence and Prevalence of Systemic Lupus Erythematosus in New York County (Manhattan), New York: The Manhattan Lupus Surveillance Program

Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTION International Clinical Database and Repository

C3 glomerulonephritis and systemic lupus erythematosus: A report of a patient treated with eculizumab and review of the literature

Population-based prevalence and incidence estimates of mixed connective tissue disease from the Manhattan Lupus Surveillance Program

Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective study

Microvascular C5b-9 deposition in non-lesional skin in patients with SLE and its correlation with active lupus nephritis: a prospective observational study

COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION)

The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody–Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository

Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry

Mild Clinical Course of COVID-19 in 3 Patients Receiving Therapeutic Monoclonal Antibodies Targeting C5 Complement for Hematologic Disorders

Modeling of clinical phenotypes in systemic lupus erythematosus based on the platelet transcriptome and FCGR2a genotype

Clinical implications of discordance between anti-dsDNA antibodies by multiplex flow immunoassay and Crithidia luciliae assay in a multiethnic racial cohort of patients with SLE

Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)

Hydroxychloroquine is associated with lower platelet activity and improved vascular health in systemic lupus erythematosus

Membrane attack complex (MAC) deposition in renal tubules is associated with interstitial fibrosis and tubular atrophy: a pilot study

Clinical and Serologic Phenotyping and Damage Indices in Patients With Systemic Lupus Erythematosus With and Without Fibromyalgia

306 Persistence of urinary biomarkers of intrarenal inflammation precedes loss of kidney function in lupus nephritis

O38 Persistence of urinary biomarkers of intrarenal inflammation precedes loss of kidney function in lupus nephritis

Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy

Erythrocyte complement receptor 1 (ECR1) and erythrocyte-bound C4d (EC4d) in the prediction of poor pregnancy outcomes in systemic lupus erythematosus (SLE)

2023 ACR/EULAR antiphospholipid syndrome classification criteria

Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways

A Woman With Painful Digital Ulcers

Suchergebnisse filtern